Giuliani Partners

Last updated
Giuliani Partners
Company type Private
Industry Management consulting
Security consulting
Real estate
Investment funds
Founded2002
Headquarters New York City, United States
Key people
 Rudy Giuliani (founder, CEO and chairman)
Revenue$40 million (est. 2007)
Number of employees
About 60 (2007)
about 50 (2008) [1]
fewer (2010) [2]
Website www.giulianipartners.com

Giuliani Partners LLC is a management consulting and security consulting business founded by former New York City Mayor Rudy Giuliani in January 2002. [3] As of 2020, Dun & Bradstreet estimated that the business had 20 employees and revenues of $6.34 million. [4]

Contents

Structure

Rudy Giuliani is chairman and CEO of Giuliani Partners. [5] Many of the managing partners and executives of Giuliani Partners are former New York City officials, counsels, or emergency services leaders, and associates from Giuliani's time as mayor. [6] There is a subsidiary of the partnership, Giuliani Security & Safety LLC (before 2005, Giuliani-Kerik), which focuses on security consulting, especially regarding buildings; [7] its chairman and CEO is Pasquale J. D'Amuro, a former assistant director in charge at the Federal Bureau of Investigation's New York office, and an inspector in charge following the September 11 attacks. [3] [7] Other subsidiaries include Giuliani Safety & Security Asia and Giuliani Compliance Japan. [3]

Giuliani Partners' stated mission expresses "dedicated to helping leaders solve critical strategic issues, accelerate growth, and enhance the reputation and brand of their organizations in the context of strongly held values ... based on six fundamental principles: Integrity, Optimism, Courage, Preparedness, Communication, Accountability." [8] "No client is ever approved or worked on without a full discussion with Rudy ... We're cautious in the right sense of that term, in terms of who we work for. We always want to make sure it is a company that is doing the right thing, that we're proud to represent", according to Giuliani Partners' senior managing partner, Michael D. Hess, former corporation counsel for New York City. [3]

Giuliani's colleagues at Giuliani Partners have included founding member and vice president Matthew Mahoney, a former deputy director of advance for the mayor's office; [9] Bernard Kerik, Giuliani's former police commissioner, who was later accused of having ties to organized crime [3] and resigned from the firm in 2004; [10] former FBI investigator D'Amuro, who admitted to taking six non-evidentiary artifacts from Ground Zero as mementos, but against whom no action was taken by the FBI; [11] and Monsignor Alan Placa, a high school friend of Giuliani and a former Roman Catholic priest who was accused of sexually molesting a teenager and of covering up molestation in the church. [12] Giuliani Partners has stated that Giuliani "believes that Alan Placa has been unjustly accused", and that the firm has no plans to stop representing him. [13]

The firm is privately held. Sources have placed Giuliani Partners' earnings at over $100 million in the five years through early 2007. [3] Another estimate shows it with annual revenues of $40 million and 55 employees. After stepping down as CEO and chairman, Giuliani retained a 30 percent equity stake in the partnership, [14] which paid him $4.1 million in 2006. [14] The firm's fortunes, which had always been dependent upon Giuliani's star power, [15] diminished due to Giuliani's absence during his campaign, which ended in late January 2008. Its client list and revenues decreased, and staff was reduced from about 60 to about 50 employees. [1] [16]

During the 2008 presidential election effort, Peter Powers was chairman and CEO of Giuliani Partners, [14] having replaced Giuliani [17] in June 2007, [14] ahead of the 2008 Rudy Giuliani presidential campaign. Peters was formerly a deputy mayor of New York. [14]

Giuliani subsequently returned to work at the firm, splitting time between it and the law firm Bracewell & Giuliani. [15] The company specialized in consulting on energy-related matters. [15] In July 2008, Giuliani Partners announced it was diversifying via the creation of a real estate investment fund that would target foreign investors seeking to capitalize on the weak dollar and invest in New York and Washington, D.C. real estate. [16] The fund would be a collaboration with Rockville, Maryland-based Berman Enterprises. [16] By mid-2009, Giuliani Partners was still feeling the effects of Giuliani's ongoing political life, including the departure of former Giuliani chief of staff Anthony V. Carbonetti, who was working on possible Giuliani-related aspects of the New York gubernatorial election, 2010. [18]

The firm's headquarters had been in 5 Times Square, at the south end of New York City's Times Square, since its founding. [3] In 2010, the firm relocated to Manhattan to share office space with the New York office of Giuliani's other law partnership, Texas law firm Bracewell & Giuliani. [2] The firm had further reduced its number of employees, and Bracewell & Giuliani became the former mayor's primary public business activity. [2]

Client base

Giuliani Partners has been categorized by various media outlets as a lobbying entity capitalizing on Giuliani's name recognition. [19] [20] Clients of Giuliani Partners are required to sign confidentiality agreements that preclude commentary about the work the firm's work and fees. [3] Giuliani has refused to talk about his clients, services rendered, compensation received, or any details about the company. [3]

One of Giuliani Partners' clients during this time was Hank Asher, an admitted drug smuggler and millionaire founder of companies that perform electronic information gathering (datamining) on individuals. According to a shareholder in the company, Asher hired Giuliani for his "influence with the federal government to enable Mr. Asher to take an active role in Seisint as a chief executive officer despite the allegations about his drug dealing". Giuliani helped Asher's company obtain $12 million in government grants. [3] After Asher's past was publicly revealed, he resigned from the company; Giuliani defended him to newspapers without mentioning that Asher was a paying client. [3] After Asher's resignation, investors in Seisint reported that Giuliani was paid US$2 million a year in fees, a commission on sales of Seisint products, and 800,000 warrants for Seisint stock, which would prove valuable when Seisent was sold to Lexis Nexis for $775 million. One investor sued the board, claiming that Giuliani's contributions had not been worth the large amount paid. [3] [21] The Seisent database product that Giuliani Partners was to help market the Multistate Anti-Terrorism Information Exchange, and was criticized on civil liberties grounds; within two years the program was disbanded. [22]

In representing Purdue Pharma, maker of OxyContin, in a case against the Drug Enforcement Administration, Giuliani Partners negotiated a $2 million fine and no further penalty for what the DEA called "lax security" at plants that produced the drug, which the DEA said was being used as a recreational drug. The lead DEA investigator later said that Purdue Pharma escaped harsher penalties in the case because of Giuliani's connections to government officials. [3] Giuliani later represented Purdue Pharma in a recently settled case in which the DEA accused the company of marketing OxyContin by playing down its level of addictive properties. Giuliani met with government lawyers six times to help negotiate a settlement in the case. [3] Giuliani reached a deal to avoid a bar on Purdue Pharma doing business with the federal government. [23]

Forbes reported in November 2006 that Giuliani Partners accepted fees from penny stock firms, made alliances that have gone nowhere, and formed pacts with businesses and individuals that have come under scrutiny by regulators and law enforcement officers. [24] For instance, Giuliani Capital Advisors accepted 1.6 million warrants from Lighting Science Group at 60 cents, a fee of $150,000 and a promise to raise cash. The company went bankrupt, losing $412,000 on sales of $137,000 in the first part of 2006. A venture with CamelBak started out under Giuliani's consulting arrangement with $31 million in sales, but was run into the ground with various missteps, including having the disgraced Bernard Kerik sit on its board. Forbes said Giuliani's most controversial deal was throwing in with a 2004 project with Applied DNA Sciences. Its backer, Richard Langley Jr., had previously pleaded guilty to conspiracy to commit wire fraud and commercial bribery in another penny stock scam; another, Jeffrey Salzwedel, had been fined for making "unsuitable" stock recommendations to clients; and the brokerage firm Vertical Capital Partners, a third backer, had been penalized repeatedly for various securities violations. [25] [26]

Mexico City hired Giuliani Partners to consult on its crime rate, hoping for a drop in crime like that which New York City had experienced in the 1990s. Giuliani toured the city for a day and Giuliani Partners produced a report analyzing ways in which crime could be reduced. However, in the year after the plan was implemented, crime dropped by only 1% and some city officials expressed regret at hiring Giuliani for a $4.3 million fee. Some called it a "$4 million publicity stunt". [3] Some of the recommendations that were put into place included using breathalyzers on drunk drivers and targeting "squeegee men". [27]

Giuliani Partners has had contracts since 2005 with Qatar's Ministry of the Interior, for security advice and consulting services. [28] These contracts were overseen by Minister Abdullah bin Khalifah Al Thani, a member of Qatar's royal family. [28]

Giuliani Capital Advisors

On December 1, 2004 his consulting firm announced it purchased accounting firm Ernst & Young's investment banking unit. The new investment bank would be known as Giuliani Capital Advisors LLC and would advise companies on acquisitions, restructurings, and other strategic issues.[ citation needed ]

On March 5, 2007, due to his presidential campaign, Giuliani Capital Advisors was sold to Macquarie Group, an Australian financial group, for an amount that analysts said may approach $100 million. [29]

Related Research Articles

<span class="mw-page-title-main">Oxycodone</span> Opioid medication

Oxycodone, sold under various brand names such as Roxicodone and OxyContin, is a semi-synthetic opioid used medically for treatment of moderate to severe pain. It is highly addictive and is a commonly abused drug. It is usually taken by mouth, and is available in immediate-release and controlled-release formulations. Onset of pain relief typically begins within fifteen minutes and lasts for up to six hours with the immediate-release formulation. In the United Kingdom, it is available by injection. Combination products are also available with paracetamol (acetaminophen), ibuprofen, naloxone, naltrexone, and aspirin.

<span class="mw-page-title-main">Rudy Giuliani</span> American attorney and politician (born 1944)

Rudolph William Louis Giuliani is an American politician and lawyer who served as the 107th mayor of New York City from 1994 to 2001. He previously served as the United States Associate Attorney General from 1981 to 1983 and the United States Attorney for the Southern District of New York from 1983 to 1989.

<span class="mw-page-title-main">Bernard Kerik</span> Former NYC police commissioner and pardoned felon

Bernard Bailey Kerik is an American consultant and former police officer who was the 40th Commissioner of the New York Police Department from 2000 to 2001. As a convicted felon, he obtained a presidential pardon from President Donald Trump in 2020 for his numerous federal convictions for tax fraud, ethics violations, and criminal false statements.

<span class="mw-page-title-main">McKinsey & Company</span> US-based worldwide management consulting firm

McKinsey & Company is an American multinational strategy and management consulting firm that offers professional services to corporations, governments, and other organizations. Founded in 1926 by James O. McKinsey, McKinsey is the oldest and largest of the "Big Three" management consultancies (MBB). The firm mainly focuses on the finances and operations of their clients.

<span class="mw-page-title-main">Arthur M. Sackler</span> American physician and marketing executive (1913–1987)

Arthur Mitchell Sackler was an American psychiatrist and marketer of pharmaceuticals whose fortune originated in medical advertising and trade publications. He was also an art collector. He was one of the three patriarchs of the controversial Sackler family pharmaceutical dynasty.

Bracewell LLP is an international law firm based in Houston, Texas, that began in 1945. The firm has approximately 350 lawyers, and has United States offices in New York City, Washington, D.C., Hartford, San Antonio, Seattle, Dallas and Austin, as well as offices in Dubai and London.

<span class="mw-page-title-main">Purdue Pharma</span> American pharmaceutical company (1892–2019 bankruptcy)

Purdue Pharma L.P., formerly the Purdue Frederick Company (1892–2019), was an American privately held pharmaceutical company founded by John Purdue Gray. It was sold to Arthur, Mortimer, and Raymond Sackler in 1952, and then owned principally by the Sackler family and their descendants.

<span class="mw-page-title-main">Rudy Giuliani 2008 presidential campaign</span> Unsuccessful presidential campaign

The 2008 presidential campaign of Rudy Giuliani began following the formation of the Draft Giuliani movement in October 2005. The next year, Giuliani opened an exploratory committee and formally announced in February 2007 that he was actively seeking the presidential nomination of the Republican Party.

Raymond Sackler was an American physician and businessman. He acquired Purdue Pharma together with his brothers Arthur M. Sackler and Mortimer Sackler. Purdue Pharma is the developer of OxyContin, the drug at the center of the opioid epidemic in the United States.

John Leslie Brownlee is an American lawyer. He was the United States Attorney for the Western District of Virginia from 2001 to 2008.

Mortimer David Sackler was an American-born psychiatrist and entrepreneur who was a co-owner, with his brothers Arthur and Raymond, of Purdue Pharma. During his lifetime, Sackler's philanthropy included donations to the Metropolitan Museum of Art, the Tate Gallery, the Royal College of Art, the Louvre and Berlin's Jewish Museum.

Reputation laundering occurs when a person or an organization conceals unethical, corrupt, or criminal behavior or other forms of controversy by performing highly visible positive actions with the intent to improve their reputation and obscure their history.

<span class="mw-page-title-main">Richard Sackler</span> American billionaire (born 1945)

Richard Stephen Sackler is an American billionaire businessman and physician who was the chairman and president of Purdue Pharma, a former company best known as the developer of OxyContin, whose connection to the opioid epidemic in the United States was the subject of multiple lawsuits and fines, and that filed for bankruptcy in 2019. It has been claimed that Richard Sackler's Purdue is among "the worst drug dealers in history" and the Sackler family have been described as the "most evil family in America". The company's downfall was the subject of the 2021 Hulu series Dopesick and the 2023 Netflix series Painkiller.

Massachusetts v. Purdue is a lawsuit filed on August 14, 2018, suing the Stamford, Connecticut-based company Purdue Pharma LP, which created and manufactures OxyContin, "one of the most widely used and prescribed opioid drugs on the market", and Purdue's owners, the Sacklers accusing them of "widespread fraud and deception in the marketing of opioids, and contributing to the opioid crisis, the nationwide epidemic that has killed thousands." Purdue denied the allegations.

Barry Meier is a writer and former New York Times journalist who wrote the 2003 non-fiction book Pain Killer: A Wonder Drug's Trail of Addiction and Death. His articles "have led to Congressional hearings and changes in federal laws".

The Sackler family is an American family who owned the pharmaceutical company Purdue Pharma and later founded Mundipharma. Purdue Pharma, and some members of the family, have faced lawsuits regarding overprescription of addictive pharmaceutical drugs, including OxyContin. Purdue Pharma has been criticized for its role in the opioid epidemic in the United States. They have been described as the "most evil family in America", and "the worst drug dealers in history".

<span class="mw-page-title-main">Timeline of the opioid epidemic</span>

The timeline of the opioid epidemic includes selected events related to the origins of Stamford, Connecticut-based Purdue Pharma, the Sackler family, the development and marketing of oxycodone, selected FDA activities related to the abuse and misuse of opioids, the recognition of the opioid epidemic, the social impact of the crisis, lawsuits against Purdue and the Sackler family.

<i>The Crime of the Century</i> (2021 film) American documentary film

The Crime of the Century is an American two-part documentary film, directed, produced, and written by Alex Gibney. The film follows the opioid epidemic in the United States, and the political operatives, government regulations and corporations that enable the abuse of opioids, particularly the Sackler family and Purdue Pharma.

Curtis Wright IV is an American former government official known for his role in the Food and Drug Administration's approval of OxyContin for Purdue Pharma in 1995, followed by his subsequent employment by the company, which led to portrayals in films and reports in nonfiction books, magazines, and news media outlets of his alleged role as one of the key figures in the current opioid epidemic in the United States. Wright was implicated in a criminal conspiracy outlined in a 2006 United States Department of Justice review document that was first made public in Purdue Pharma's 2019 bankruptcy proceedings. Although that case was settled in a 2007 plea agreement deal, members of United States Congress have requested the full 2006 documentation from the Department of Justice with the goal of opening a new case based upon the evidence then gathered. Parts of Wright's sworn depositions in 2003 and 2018 have internal contradictions and differ from documentary evidence described the 2003–2006 U.S. Federal Government investigation into Purdue Pharma.

Harrington v. Purdue Pharma L.P.,, is a pending United States Supreme Court case regarding Chapter 11 of the Bankruptcy Code. This case is about the settlement by Purdue Pharmaceutical for Opioid victims who overdosed with the OxyContin drug produced by their company.

References

  1. 1 2 Eric Lipton (2008-02-01). "Giuliani Will Return Diminished, but Not Finished, Associates Say". The New York Times . Retrieved 2008-07-23.
  2. 1 2 3 Haberman, Maggie (2010-09-02). "Giuliani Partners closes Times Square office". The Politico . Retrieved 2010-09-12.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 "In Private Sector, Giuliani Parlayed Fame Into Wealth", The Washington Post , May 13, 2007. Accessed June 8, 2007.
  4. ↑ "Giuliani Partners LLC". Dun & Bradstreet. 2020. Retrieved November 19, 2020.
  5. ↑ "Company Overview of Giuliani Partners LLC". Bloomberg. Retrieved 12 March 2017.
  6. ↑ "Giuliani Partners - Michael D. Hess". Archived from the original on 2007-06-27. Retrieved 2007-07-04.
  7. 1 2 "Giuliani Partners - Pasquale J. D'Amuro". Archived from the original on 2007-06-16. Retrieved 2007-07-04.
  8. ↑ "Giuliani Partners - Philosophy". Archived from the original on 2007-08-14. Retrieved 2007-07-04.
  9. ↑ Benjamin, Elizabeth (2008-03-20). "Senate GOP Hires Ex-Giuliani Aide". New York Daily News . Archived from the original on 2011-06-04.
  10. ↑ Rashbaum, William K. (2007-11-24). "Kerik Loan Activity Is Brought to Light After Indictment". The New York Times .
  11. ↑ "The Giuliani Files", The Washington Post . Accessed July 5, 2007.
  12. ↑ Michael Powell, "Loyal to Kerik, Giuliani Missed Warning Signs", The New York Times, November 3, 2007
  13. ↑ "Giuliani Pressured To Drop Clergy Pal". CBS News . Associated Press. 2007-06-23. Retrieved 2007-11-09.
  14. 1 2 3 4 5 Tom Brune (2007-12-05). "Rudy no longer firm CEO". Newsday . Retrieved 2007-12-06.
  15. 1 2 3 Santora, Marc (2008-08-16). "How's Life for Giuliani These Days? Quite Busy". The New York Times . Retrieved 2008-12-11.
  16. 1 2 3 Santora, Marc (2008-07-20). "Giuliani Firm Plans Real Estate Investment Fund". The New York Times . Retrieved 2008-07-23.
  17. ↑ "Giuliani Partners - Rudolph W. Giuliani". Archived from the original on 2007-06-27. Retrieved 2007-07-04.
  18. ↑ Hakim, Danny (2009-08-24). "Giuliani, Seeing Opening, Mulls a Governor Bid". The New York Times . Retrieved 2009-08-25.
  19. ↑ "New York News, Traffic, Sports, Weather, Photos, Entertainment, and Gossip - NY Daily News". Daily News. New York. Archived from the original on February 11, 2007.
  20. ↑ American Idol
  21. ↑ Giuliani: Worse Than Bush : Rolling Stone
  22. ↑ Michael Weisskopf, Massimo Calabresi (2007-12-13). "Rudy: All Business". Time . Archived from the original on December 21, 2007. Retrieved 2007-12-13.
  23. ↑ Chris McGreal. "Rudy Giuliani won deal for OxyContin maker to continue sales of drug behind opioid deaths". TheGuardian.com . Retrieved 22 May 2018.
  24. ↑ "The Company He Keeps". Forbes. 2006-11-13. Archived from the original on 2007-11-15. Retrieved 2007-11-07.
  25. ↑ Iwata, Edward (2005-03-18). "Giuliani firm's deal to advise company raises questions". USA Today. Retrieved 2010-05-03.
  26. ↑ "Giuliani firm deal questioned". CNN. 2005-03-18. Retrieved 2010-05-03.
  27. ↑ "In Mexico City, Few Cheers for Giuliani", nysun.com, April 11, 2005. Accessed June 8, 2007.
  28. 1 2 Marcus Baram (2007-11-29). "Giuliani's Ties to Qatar Raise Questions for Mr. 9/ll". ABC News . Archived from the original on 2007-12-01. Retrieved 2007-12-09.
  29. ↑ "Giuliani sells bank in presidential campaign move", FT.com, March 5, 2007. Accessed March 5, 2007.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.